title: Replacing warfarin for better or worse: identifying patient factors and future directions.
authors.affiliation: School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC. basia.diug@monash.edu
authors.forename: Basia O
authors.initials: BO
authors.lastname: Diug
authors.forename: Judy A
authors.initials: JA
authors.lastname: Lowthian
authors.forename: Michael
authors.initials: M
authors.lastname: Dooley
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D001315:Australia; D005260:Female; D005544:Forecasting; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D061214:Patient Safety; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D020521:Stroke / Q000401:mortality / Q000517:prevention & control; D016019:Survival Analysis; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D014859:Warfarin